Seung Suh Hong
CIK: 0001774271
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OCUL
OCULAR THERAPEUTIX, INC
Director
Discretionary Trading P&L
Holdings
About Hong Seung Suh
Hong Seung Suh (SEC CIK 0001774271) files insider reports with the SEC as Director of OCULAR THERAPEUTIX, INC (OCUL).
Signal8 holds 2 ownership filings by Hong Seung Suh, all Form 4s, filed between Jun 13, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hong Seung Suh's filings is in BEDFORD, MA.
Recent filings by Hong Seung Suh
Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)
- Anderman Todd, Chief Legal Officer
- Kaiser Peter, Chief Development Officer
- Heier Jeffrey S., Chief Scientific Officer
- Notman Donald, Chief Operating Officer
- Nayak Sanjay, Chief Strategy Officer
- Dugel Pravin